JP2007536913A - 神経障害性疼痛の代用マーカー - Google Patents

神経障害性疼痛の代用マーカー Download PDF

Info

Publication number
JP2007536913A
JP2007536913A JP2006554241A JP2006554241A JP2007536913A JP 2007536913 A JP2007536913 A JP 2007536913A JP 2006554241 A JP2006554241 A JP 2006554241A JP 2006554241 A JP2006554241 A JP 2006554241A JP 2007536913 A JP2007536913 A JP 2007536913A
Authority
JP
Japan
Prior art keywords
nucleic acid
protein
seq
amount
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006554241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007536913A5 (https=
Inventor
ダイナー ダブリュー． ワイ． サー，
リチャード ケイト，
クリスチャン ダブリュー． エレンフェルズ，
スザンヌ スザック，
ラジャセッカー バンダル，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Biogen MA Inc
Original Assignee
Biogen Inc
Biogen Idec Inc
Biogen Idec MA Inc
Biogen MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc, Biogen Idec Inc, Biogen Idec MA Inc, Biogen MA Inc filed Critical Biogen Inc
Publication of JP2007536913A publication Critical patent/JP2007536913A/ja
Publication of JP2007536913A5 publication Critical patent/JP2007536913A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
JP2006554241A 2004-02-20 2005-02-18 神経障害性疼痛の代用マーカー Withdrawn JP2007536913A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/784,004 US20060084066A1 (en) 2004-02-20 2004-02-20 Surrogate markers of neuropathic pain
PCT/US2005/005250 WO2005083125A2 (en) 2004-02-20 2005-02-18 Surrogate markers of neuropathic pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008035087A Division JP2008188014A (ja) 2004-02-20 2008-02-15 神経障害性疼痛の代用マーカー

Publications (2)

Publication Number Publication Date
JP2007536913A true JP2007536913A (ja) 2007-12-20
JP2007536913A5 JP2007536913A5 (https=) 2008-04-10

Family

ID=34911413

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006554241A Withdrawn JP2007536913A (ja) 2004-02-20 2005-02-18 神経障害性疼痛の代用マーカー
JP2008035087A Withdrawn JP2008188014A (ja) 2004-02-20 2008-02-15 神経障害性疼痛の代用マーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008035087A Withdrawn JP2008188014A (ja) 2004-02-20 2008-02-15 神経障害性疼痛の代用マーカー

Country Status (6)

Country Link
US (1) US20060084066A1 (https=)
EP (2) EP1721013A2 (https=)
JP (2) JP2007536913A (https=)
AU (1) AU2005217406A1 (https=)
CA (1) CA2556925A1 (https=)
WO (1) WO2005083125A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050037946A1 (en) * 2003-01-13 2005-02-17 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
US7947436B2 (en) * 2004-12-13 2011-05-24 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US7943732B2 (en) 2006-06-05 2011-05-17 Intrexon Corporation AKT ligands and polynucleotides encoding AKT ligands
WO2008121385A2 (en) * 2007-03-30 2008-10-09 Children's Hospital Medical Center Compositions and methods useful for modulating spondyloarthropathies
EP2348128A1 (en) * 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
US10512655B1 (en) 2013-03-12 2019-12-24 Jeffrey S. Brooks, Inc. Methods and compositions for the topical treatment of peripheral neuropathy
CN109195635A (zh) * 2015-08-31 2019-01-11 清华大学 磁遗传学及其用途
WO2024039740A2 (en) * 2022-08-16 2024-02-22 Gro Biosciences Inc. Polypeptide compositions containing non-standard glycan stub amino acids and methods of making and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US6071247A (en) 1996-07-21 2000-06-06 Kennedy; William R. Skin blister biopsy apparatus and method
EP1250460A2 (en) * 2000-01-14 2002-10-23 Integriderm L.L.C. Informative nucleic acid arrays and methods for making same
US20030216341A1 (en) * 2002-02-14 2003-11-20 Hermann Lubbert Multiple genes relevant for the characterization, diagnosis, and manipulation of neuropathic pain
US20040019006A1 (en) * 2002-05-10 2004-01-29 Yoshihide Hayashizaki Novel genes relating to pain and use of the genes for pharmaceuticals

Also Published As

Publication number Publication date
WO2005083125A2 (en) 2005-09-09
EP1721013A2 (en) 2006-11-15
CA2556925A1 (en) 2005-09-09
JP2008188014A (ja) 2008-08-21
AU2005217406A1 (en) 2005-09-09
EP1980628A3 (en) 2009-01-07
EP1980628A2 (en) 2008-10-15
WO2005083125A3 (en) 2005-12-08
US20060084066A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
JP2008188014A (ja) 神経障害性疼痛の代用マーカー
KR102089559B1 (ko) 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도
CN102762742A (zh) 用于红斑痤疮的诊断的标记物和方法
US20240200137A1 (en) Method for the prognosis and/or diagnosis of a disease based on a sample of adipose tissue, and a kit for said method
EP2300624B1 (en) Biomarkers for painful intervertebral discs and methods of use thereof
Morgan et al. Characterization of a model of chronic orofacial hyperalgesia in the rat: contribution of NAV 1.8
TW202300658A (zh) 具毛囊再生能力之細胞之鑑定方法、及用於使毛囊再生之組合物之評估方法
WO2023142230A1 (zh) 一种慢性疼痛治疗靶点及其应用
US20220244272A1 (en) In vitro test method for early detection of endometriosis and/or uterine adenomyosis
AU1794901A (en) Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
EP3607095A1 (en) Kit and method for determining the receptivity status of an endometrium
CN110093416A (zh) 生物标志物在诊断骨科疾病中的应用
EP2123773A1 (en) Use of GPR151 modulators for the treatment of pain
CN111197088A (zh) Adamtsl3作为腹主动脉瘤诊治标志物的应用
Sekhar et al. Glynac supplementation in older adults protects from meal driven oxidative stress and inflammation: Results of a rct
CN109295209B (zh) 骨关节炎诊治标志物gpa33及其用途
KR20180032953A (ko) Card18 발현 촉진 물질을 포함하는 피부 장벽기능 강화용 조성물 및 card18 촉진 물질의 스크리닝 방법
KR20250172268A (ko) 식품알레르기 진단, 예후 예측, 치료 또는 예방을 위한 조성물
US20020042054A1 (en) Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
Stojanović et al. Evaluation of the reference genes in human adipose tissue and lipoma samples.
CN114480627A (zh) 用于重性抑郁障碍诊断的circRNA标志物及其应用
EP2121955B1 (en) Method of use of epiregulin protein and nucleic acid encoding the same in inflammatory conditions
CN112662757A (zh) 一种用于脓毒症诊断的生物标志物
EP3434766A1 (en) Detection method and detection kit for detecting dry age-related macular degeneration
Miro et al. Histomorphometric Characterization of the Endometrium in Mules (Equus mulus): an approach to endometritis/endometriosis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080215

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090501